Russia Escalates Ukraine Conflict Threatens Additional Strikes on Kyiv Urges Foreign Nationals to Depart Wipros Rs 15000 Crore Share Buyback at 23 Premium Key Details and Market Implications Indias Education Loans Surge 15 to Hit DecadeHigh 858 Lakh Crore in FY26 Key Economic Data and Corporate Earnings to Watch This Week Jim Cramer Analyzes NVIDIAs Latest Quarterly Performance Key Insights for Investors Applied Digital Signs Major Hyperscaler Lease at Polaris Forge 3 Campus What It Means for Growth ColgatePalmolive Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Operations CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape AA Q1 2026 Earnings EPS Misses Estimates Shares Climb on Strategic Optimism NCTY Q1 2012 Earnings Narrower Loss Beats Estimates but Stock Slides TGT Q1 2026 Earnings EPS Surprises to the Upside Stock Reacts Positively Chiron Real Estate Inc XRN Holds Steady Near 3742 as Support and Resistance Levels Remain Key GECCH Notes Dip 16 Support Levels and Yield Dynamics in Focus Compass Inc COMP Edges Higher Navigating Support and Resistance Levels RZC Holds Steady Near Par as Investors Assess FixedRate Reset Features Columbus Circle Capital Corp II CMII Holds Steady Near 991 Amid Flat Trading SpaceX IPO Filing Draws Market Attention KraneShares AGIX Offers Indirect Space Exposure CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline InflaRx NV IFRX Surges 75 as Shares Test Key Resistance Level abrdn FCO Stock Down 077 Support Test at 244 20260515 AI Accelerates New Business Formation Gen Z Entrepreneurs Lead the Charge Gusto Report Elon Musk Vows to Appeal After Jury Ruling Against Him in OpenAI Trial Anika ANIK Q1 2026 Earnings Surprise EPS 027 Up Significant Why Vijay Kedia Suggests Indias Tourism Sector Could Emerge as a TrillionDollar Opportunity Kinross Gold Continues Capital Return Strategy While Major Growth Projects Move Forward MIRA Pharmaceuticals MIRA Q3 2025 Earnings Why the Beat Matters